Advocacy intelligence hub — real-time data for patient organizations
I.R.C.C.S. Fondazione Santa Lucia — PHASE4
Wuhan Pulmonary Hospital — NA
Boston University — PHASE2
AmBisome: FDA approved
Treatment of visceral leishmaniasis.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
AmBisome
Fujisawa USA, Inc.
AmBisome
(Liposomal amphotericin B)Orphan drugFujisawa USA, Inc.
Lipid-based Polyene Antifungal [EPC]
Jeevi Mona Priyadharshni Selvarajan
Tata Memorial Hospital (TMH)/Advanced Centre for Treatment Research & Education in Cancer (ACTREC)
Sridhar Epari
Tata Memorial Hospital (TMH)/Advanced Centre for Treatment Research & Education in Cancer (ACTREC)
Arpita Sahu
Tata Memorial Hospital (TMH)/Advanced Centre for Treatment Research & Education in Cancer (ACTREC)
Archya Dasgupta
Tata Memorial Hospital (TMH)/Advanced Centre for Treatment Research & Education in Cancer (ACTREC)
Abhishek Chatterjee, M.D., M.B.A
Tata Memorial Hospital (TMH)/Advanced Centre for Treatment Research & Education in Cancer (ACTREC)
📍 LEBANON, NH
Tejpal Gupta
Tata Memorial Hospital (TMH)/Advanced Centre for Treatment Research & Education in Cancer (ACTREC)